TITLE

Aventis seed lines to go

AUTHOR(S)
Abel, Charles
PUB. DATE
May 2002
SOURCE
Farmers Weekly;5/10/2002, Vol. 136 Issue 19, p61
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Presents information on the plan of Bayer to acquire agricultural chemicals manufacturer Aventis Agroscience. Background of the companies; Details of the seed treatment business of Aventis.
ACCESSION #
6910148

 

Related Articles

  • Takeda's agro grows.  // Chemical Week;9/17/1997, Vol. 159 Issue 35, p31 

    Reports that Agro, a Takeda Chemical Industries subsidiary is collaborating with Monsanto and Bayer in the development of pesticides. Implication of the collaboration on Agro's operation.

  • Bayer to boost engineering resins.  // Chemical Week;9/13/1995, Vol. 157 Issue 9, p5 

    Reports that Bayer will invest $20 million at its Ohio plant to more than double production of engineering thermoplastics for computer housings, medical equipment and automotive applications. Product lines.

  • Protests block Bayer TDI plan.  // Chemical Week;9/18/96, Vol. 158 Issue 35, p8 

    Reports that Taiwan's Taichung government has ordered a second environmental impact study of Bayer's proposed toluene diisocyanate plant in the province's port in response to local protests.

  • Bayer to boost U.S. presence. D'Amico, Esther // Chemical Week;9/18/96, Vol. 158 Issue 35, p15 

    Reports on Bayer's plans to expand and modernize its veterinary medicine facilities in Shawnee, Kansas. Launching of a flea product for cats and dogs called Advantage; Aim of raising market share in the animal health industry before the year 2000.

  • Bayer optimistic about prospects. Wood, Andrew // Chemical Week;10/9/96, Vol. 158 Issue 38, p14 

    Reports on Bayer's optimism about its prospects in the Mexican chemical market. Plans to invest in capital projects in Mexico through the year 2000.

  • Elephant walk. Reier, Sharon // FW;2/28/95, Vol. 164 Issue 6, p38 

    Focuses on German chemicals and pharmaceuticals firm Bayer. Cost-cutting measures spearheaded by CEO Manfred Schneider; Corporate history; Growth rate of pharmaceuticals; Success in drug research; Growth strategy; Financial standing.

  • Three vie for $350M global Bayer business. Wilke, Michael // Advertising Age;10/30/95, Vol. 66 Issue 44, p2 

    Reports on Bayer AG's review of its global consumer products advertising account. Advertising agencies vying for the account; Industry observers' comments.

  • Bayer results give cause for hope.  // Chemical Week;3/23/94, Vol. 154 Issue 11, p8 

    Reports on Bayer's economic performance in 1993. Decrease in net income and pretax profits; Comparison of Bayer's performance with BASF and Hoechst; Data on investment and research costs.

  • Bayer spending big on PU, PC at Baytown. Renstrom, Roger // Plastics News;4/7/1997, Vol. 9 Issue 6, p5 

    States that Bayer Group's subsidiary in the United States will increase production of engineering thermoplastics polycarbonate, and two polyurethane components at its Baytown, Texas facility. Comments fron Helge H. Wehmeier, president and chief executive officer for Pittsburgh-based Bayer...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics